White label ELPA - ClinicalTrials.eu

Study on Eptinezumab for Preventing Chronic Migraine in Adults

Not recruiting

3 1 1 1
Investigated diseases:
- Migraine
Investigated drugs:
- Eptinezumab
Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Not recruiting

3 1 1 1
Investigated diseases:
- Follicle centre lymphoma follicular grade I II – III refractory
Investigated drugs:
+8
Study on the Effects of Selpercatinib in Patients Aged 12 and Older with Advanced Solid Tumors with RET Gene Alteration

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Selpercatinib
Study on Venetoclax and Dexamethasone for Patients with Relapsed and Refractory Multiple Myeloma with Translocation (11;14)

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study on Esomeprazole Magnesium for Maintaining Healing of Erosive Esophagitis in Children Aged 1 to 11 Years

Not recruiting

3 1 1 1
Investigated diseases:
- Erosive oesophagitis
Investigated drugs:
- Esomeprazole Magnesium
Study Comparing Erdafitinib with Vinflunine, Docetaxel, or Pembrolizumab for Patients with Advanced Urothelial Cancer and FGFR Gene Changes

Not recruiting

3 1 1 1
Investigated diseases:
- Transitional cell carcinoma
Investigated drugs:
Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Not recruiting

3 1 1 1
Investigated diseases:
- Diffuse large B-cell lymphoma
Investigated drugs:
+10
Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

Not recruiting

2 1
Investigated diseases:
- Amyotrophic lateral sclerosis
Investigated drugs:
- Utreloxastat
+5
Study of Tucatinib and Trastuzumab for Patients with Advanced Solid Tumors with HER2 Changes

Not recruiting

2 1 1 1
Investigated diseases:
- Cholangiocarcinoma
Investigated drugs:
Study on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease

Not recruiting

3 1 1 1
Investigated diseases:
- Anti-neutrophil cytoplasmic antibody positive vasculitis
- End stage renal disease
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies